Literature DB >> 23557265

Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.

Jagadeesh Bayry1, Timothy R Radstake.   

Abstract

The European Workshop on Immune-Mediated Inflammatory Diseases aims to exchange scientific knowledge and promote the collaboration between various disciplines (rheumatology, dermatology and gastroenterology) among physicians and scientists. This year ophthalmologists and neurologists were also present for the first time. The meeting revolved around the following topics: fibrosis, gene therapy in ophthalmology, functional genomics, challenges in human immunology, environmental factors, diabetes and metabolism, novelties in multiple sclerosis and innate lymphoid cells. The workshop was preceded by a masterclass that covered the last 15 years of IL-17/Th17 research and provided an overview on future therapeutics to battle immune-mediated inflammatory diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23557265     DOI: 10.1586/eci.13.10

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  5 in total

1.  Transethnic associations among immune-mediated diseases and single-nucleotide polymorphisms of the aryl hydrocarbon response gene ARNT and the PTPN22 immune regulatory gene.

Authors:  Shepherd H Schurman; Terrance P O'Hanlon; John A McGrath; Artiom Gruzdev; Arsun Bektas; Hong Xu; Stavros Garantziotis; Darryl C Zeldin; Frederick W Miller
Journal:  J Autoimmun       Date:  2019-11-21       Impact factor: 7.094

2.  A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?

Authors:  Jessica D Forbes; Chih-Yu Chen; Natalie C Knox; Ruth-Ann Marrie; Hani El-Gabalawy; Teresa de Kievit; Michelle Alfa; Charles N Bernstein; Gary Van Domselaar
Journal:  Microbiome       Date:  2018-12-13       Impact factor: 14.650

3.  Effectiveness of interdisciplinary combined dermatology-gastroenterology-rheumatology clinical care compared to usual care in patients with immune-mediated inflammatory diseases: a parallel group, non-blinded, pragmatic randomised trial.

Authors:  Kasper Fjellhaugen Hjuler; Anders Dige; Jørgen Agnholt; Trine Bay Laurberg; Anne Gitte Loft; Louise Faurskov Møller; Robin Christensen; Lars Iversen
Journal:  BMJ Open       Date:  2021-04-28       Impact factor: 2.692

Review 4.  Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation.

Authors:  Matteo Puccetti; Marilena Pariano; Claudio Costantini; Stefano Giovagnoli; Maurizio Ricci
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-10

Review 5.  The Gut Microbiota in Immune-Mediated Inflammatory Diseases.

Authors:  Jessica D Forbes; Gary Van Domselaar; Charles N Bernstein
Journal:  Front Microbiol       Date:  2016-07-11       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.